Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    CD44v10 Monoclonal Antibody (VFF-14)
 
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
CD44v10 Monoclonal Antibody (VFF-14)
Supplier: Thermo Scientific MA516963
Description
 
            Specifications
| CD44v10 | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with no preservative | |
| P16070 | |
| CD44 | |
| proprietary. | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG1 | 
| Flow Cytometry, Western Blot | |
| VFF-14 | |
| Unconjugated | |
| CD44 | |
| AL133330.1; AU023126; AW121933; AW146109; Cd44; CD44 antigen; CD44 molecule (Indian blood group); CD44 splice variant; CD44 var; CD44 variant; CD44A; CD44v10; CDw44; cell surface glycoprotein CD44; Cell surface glycoprotein CD44 (hyaluronate binding protein); chondroitin sulfate proteoglycan 8; CSPG8; ECMRIII; ECMR-III; epican; Extracellular matrix receptor III; GP90 lymphocyte homing/adhesion receptor; H-CAM v10; HCELL; hematopoietic cell E- and L-selectin ligand; heparan sulfate proteoglycan; HERMES; Hermes antigen; homing function and Indian blood group system; HUTCHI; HUTCH-I; Hyaluronate receptor; IN; LHR; Ly-24; Lymphocyte antigen 24; MC56; MDU2; MDU3; METAA; MGC10468; MIC4; MUTCH-I; PGP I; Pgp1; PGP-1; PGP-I; phagocytic glycoprotein 1; Phagocytic glycoprotein I; RHAMM; soluble CD44 | |
| Mouse | |
| Purified | |
| RUO | |
| 960 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction
            